Three component salts of fumaric acid monomethyl ester and piperazine or ethylenediamine for the treatment of multiple sclerosis

• 收藏
• 分享

专利权人:

セリックス バイオ プライヴェート リミテッド

发明人:

マヘッシュ カンドゥラ

申请号：

JP2017541179

公开号：

JP6564868B2

申请日:

2014.12.29

申请国别(地区):

JP

年份:

2019

代理人:

摘要：

The invention relates to the compounds of formula I and formula II or its pharmaceutical acceptable polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of salts of formula I or formula II； and methods for treating or preventing multiple sclerosis may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of neurodegenerative diseases and psoriasis.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/